Eversept Partners, LP
- SEC CIK
- 0001697013
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 61
- 較 2023 年第 2 季 −5
- 總值
- $9.01 億
- 較 2023 年第 2 季 −$4,618 萬 (−4.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| GSKGSK plc | ADR | 3,259,342 | $1.18 億 | 13.1% | +378,330+13.1% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 2,492,636 | $1.10 億 | 12.2% | +78,849+3.3% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 6,952,085 | $7,091 萬 | 7.9% | −715,959−9.3% | 減碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 267,903 | $6,051 萬 | 6.7% | +7,505+2.9% | 加碼 | 歷史 |
| INSPInspire Medical Systems, Inc. | COM | 193,018 | $3,830 萬 | 4.3% | +110,573+134.1% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,596,245 | $3,770 萬 | 4.2% | +406,513+18.6% | 加碼 | 歷史 |
| HCAHCA Healthcare, Inc. | COM | 110,073 | $2,708 萬 | 3.0% | +29,348+36.4% | 加碼 | 歷史 |
| TECHBIO-TECHNE Corp | COM | 385,889 | $2,627 萬 | 2.9% | +43,252+12.6% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 103,784 | $2,575 萬 | 2.9% | +439+0.4% | 加碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 338,516 | $2,473 萬 | 2.7% | +338,516 | 新進 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 205,815 | $2,381 萬 | 2.6% | −269,495−56.7% | 減碼 | 歷史 |
| ILMNIllumina, Inc. | COM | 166,782 | $2,290 萬 | 2.5% | +42,730+34.4% | 加碼 | 歷史 |
| CYHCommunity Health Systems Inc | COM | 7,146,088 | $2,072 萬 | 2.3% | −131,768−1.8% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 1,478,489 | $2,027 萬 | 2.3% | −262,462−15.1% | 減碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 2,479,103 | $1,755 萬 | 1.9% | +106,990+4.5% | 加碼 | 歷史 |
| SWAVShockwave Medical, Inc. | COM | 84,462 | $1,682 萬 | 1.9% | +64,324+319.4% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 588,143 | $1,619 萬 | 1.8% | −197,597−25.1% | 減碼 | 歷史 |
| CNCCentene Corp | Stock | 190,607 | $1,313 萬 | 1.5% | +37,874+24.8% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 108,771 | $1,262 萬 | 1.4% | +2,306+2.2% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 252,446 | $1,145 萬 | 1.3% | +10,874+4.5% | 加碼 | 歷史 |
| AMRXAmneal Pharmaceuticals, Inc. | COM STK CL A | 2,644,988 | $1,116 萬 | 1.2% | −2,620,263−49.8% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 190,430 | $970.8 萬 | 1.1% | −5,261−2.7% | 減碼 | 歷史 |
| Taro Pharmaceutical Inds LtdM8737E108 | SHS | 255,323 | $962.8 萬 | 1.1% | +5,037+2.0% | 加碼 | – |
| ELVElevance Health, Inc. | Stock | 21,694 | $944.6 萬 | 1.0% | +19,379+837.1% | 加碼 | 歷史 |
| LQDALiquidia Corp | COM NEW | 1,395,454 | $884.7 萬 | 1.0% | +470,010+50.8% | 加碼 | 歷史 |
| HUMHumana Inc | Stock | 18,121 | $881.6 萬 | 1.0% | +6,194+51.9% | 加碼 | 歷史 |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 8,431,875 | $775.7 萬 | 0.9% | −2,070,234−19.7% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 443,270 | $680.0 萬 | 0.8% | +443,270 | 新進 | 歷史 |
| WATWaters Corp | COM | 23,124 | $634.1 萬 | 0.7% | +12,196+111.6% | 加碼 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 660,618 | $611.1 萬 | 0.7% | −31,751−4.6% | 減碼 | 歷史 |
| TSVT2seventy bio, Inc. | COMMON STOCK | 1,453,378 | $569.7 萬 | 0.6% | +1,453,378 | 新進 | 歷史 |
| MCRBSeres Therapeutics, Inc. | COM | 2,352,556 | $559.9 萬 | 0.6% | −724,200−23.5% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,705,774 | $539.0 萬 | 0.6% | +1,705,774 | 新進 | 歷史 |
| IFRXInflaRx N.V. | COM | 1,737,544 | $517.8 萬 | 0.6% | −177,569−9.3% | 減碼 | 歷史 |
| ICLRIcon PLC | COM | 20,998 | $517.1 萬 | 0.6% | −50,728−70.7% | 減碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 286,748 | $478.3 萬 | 0.5% | +172,089+150.1% | 加碼 | 歷史 |
| AAgilent Technologies, Inc. | COM | 41,825 | $467.7 萬 | 0.5% | +13,365+47.0% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 122,643 | $466.5 萬 | 0.5% | +66,194+117.3% | 加碼 | 歷史 |
| IQVIQVIA Holdings Inc. | Stock | 23,041 | $453.3 萬 | 0.5% | +4,293+22.9% | 加碼 | 歷史 |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 452,323 | $452.3 萬 | 0.5% | +452,323 | 新進 | 歷史 |
| PBYIPuma Biotechnology, Inc. | COM | 1,681,149 | $442.1 萬 | 0.5% | +22,954+1.4% | 加碼 | 歷史 |
| PNTGPennant Group, Inc. | COM | 365,899 | $407.2 萬 | 0.5% | −65,723−15.2% | 減碼 | 歷史 |
| MOHMolina Healthcare, Inc. | COM | 12,234 | $401.1 萬 | 0.4% | −9,020−42.4% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 4,427,857 | $368.8 萬 | 0.4% | +3,678,160+490.6% | 加碼 | 歷史 |
| RVTYRevvity, Inc. | COM | 32,698 | $362.0 萬 | 0.4% | +11,384+53.4% | 加碼 | 歷史 |
| Curevac N VN2451R105 | COM | 516,794 | $353.0 萬 | 0.4% | +159,452+44.6% | 加碼 | – |
| BHVNBiohaven Ltd. | COM | 131,103 | $341.0 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| PODDInsulet Corp | Stock | 21,299 | $339.7 萬 | 0.4% | +21,299 | 新進 | 歷史 |
| MRUSMerus N.V. | COM | 134,010 | $316.0 萬 | 0.4% | +2,784+2.1% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 769,638 | $267.1 萬 | 0.3% | +21,726+2.9% | 加碼 | 歷史 |
| RGENRepligen Corp | COM | 16,153 | $256.8 萬 | 0.3% | −49,914−75.6% | 減碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 4,565 | $224.4 萬 | 0.2% | +411+9.9% | 加碼 | 歷史 |
| MEDPMedpace Holdings, Inc. | COM | 8,823 | $213.6 萬 | 0.2% | −6,741−43.3% | 減碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 84,495 | $178.1 萬 | 0.2% | +84,495 | 新進 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 20,000 | $146.0 萬 | 0.2% | +20,000 | 新進 | – |
| XOMAXOMA Royalty Corp | COM NEW | 89,950 | $126.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| BDTXBlack Diamond Therapeutics, Inc. | COM | 337,131 | $96.8 萬 | 0.1% | −90,186−21.1% | 減碼 | 歷史 |
| Affimed N VN01045108 | COM | 1,676,684 | $80.1 萬 | 0.1% | 00.0% | 不變 | – |
| JBIOJade Biosciences, Inc. | COM | 50,242 | $68.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 101,918 | $49.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 124,589 | $35.5 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（8 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| Invesco QQQ Trust Series I46090E103 | ETF | $1.43 億 | – |
| SPYSPDR S&P 500 ETF Trust | ETF | $1.03 億 | – |
| iShares Tr464287556 | ISHARES BIOTECH | $859.7 萬 | – |
| iShares Tr464287432 | 20 YR TR BD ETF | $831.0 萬 | – |
| iShares Tr464288513 | IBOXX HI YD ETF | $663.5 萬 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $584.2 萬 | – |
| AMNAmn Healthcare Services Inc | COM | $425.9 萬 | – |
| BBIOBridgeBio Pharma, Inc. | COM | $147.1 萬 | – |
2023 年第 2 季之後清倉（13 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CTLTCatalent, Inc. | COM | 356,875 | $1,547 萬 | 1.6% | 歷史 |
| Abcam PLC000380204 | ADS | 499,394 | $1,222 萬 | 1.3% | – |
| MODNModel N, Inc. | COM | 223,168 | $789.1 萬 | 0.8% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 171,378 | $659.8 萬 | 0.7% | 歷史 |
| KURAKura Oncology, Inc. | COM | 450,622 | $476.8 萬 | 0.5% | 歷史 |
| EHTHeHealth, Inc. | COM | 503,079 | $404.5 萬 | 0.4% | 歷史 |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,327,857 | $293.5 萬 | 0.3% | 歷史 |
| GOCOGoHealth, Inc. | CL A NEW | 104,820 | $206.6 萬 | 0.2% | 歷史 |
| EOLSEvolus, Inc. | COM | 228,679 | $166.2 萬 | 0.2% | 歷史 |
| ZLABZai Lab Ltd | ADR | 55,176 | $153.0 萬 | 0.2% | 歷史 |
| URGNUroGen Pharma Ltd. | COM | 74,797 | $77.4 萬 | 0.1% | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 48,788 | $32.7 萬 | <0.1% | 歷史 |
| KYNBKyntra Bio, Inc. | COM | 5,600 | $1.51 萬 | <0.1% | 歷史 |